D-0467-2023 Class III Terminated

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0467-2023 was initiated by Zydus Pharmaceuticals (USA) Inc on Feb 24, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine. The recall status is terminated (terminated Jul 1, 2025). Affected quantity: 21,936/30 count bottles and 33,096/100 count bottles.

Recall details

Product Type
Drugs
Report Date
Mar 22, 2023
Initiation Date
Feb 24, 2023
Termination Date
Jul 1, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21,936/30 count bottles and 33,096/100 count bottles

Product description

Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC 16714-0039-02, Manufactured for: NorthStar Rx LLC., Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, c) 100 tablets per bottle, NDC 70710-1351-01, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Reason for recall

Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

Distribution pattern

AZ, OH, MS.

Code information

Lot #s: a) E203821, Exp. 05/2024; b) E203822, Exp. 05/2024, E206186, Exp. 10/2024; c) E203820, Exp. 05/2024.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0467-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0467-2023. Report a data issue: hello@regdatalab.com.